لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Lee LYW; Department of Oncology, University of Oxford; Institute of Cancer and Genomic Sciences, University of Birmingham; Institute of Immunology and Immunotherapy, University of Birmingham. Electronic address: lennard.lee@oncology.ox.ac.uk., Ionescu MC; UK Health Security Agency (UKHSA)., Starkey T; Institute of Cancer and Genomic Sciences, University of Birmingham., Little M; Department of Oncology, Oxford University Hospitals NHS Foundation Trust., Tilby M; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust., Tripathy AR; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust., Mckenzie HS; Oncology Department, University Hospitals Southampton NHS Foundation Trust., Al-Hajji Y; Birmingham Medical School, University of Birmingham., Appanna N; University of Oxford., Barnard M; University of Oxford., Benny L; UK Health Security Agency (UKHSA)., Burnett A; Sheffield Teaching Hospitals NHS Foundation Trust., Cattell EL; Department of Cancer, Taunton and Somerset NHS Foundation Trust., Clark JJ; Department of Surgery and Cancer, Imperial College London., Khan S; Leicester Cancer Research Centre, University of Leicester., Ghafoor Q; University Hospitals Birmingham NHS Foundation Trust., Panneerselvam H; Department of Oncology, Wye Valley NHS Foundation Trust., Illsley G; UK Health Security Agency (UKHSA)., Harper-Wynne C; Kent Oncology Centre, Kent and Medway Medical School, University of Kent., Hattersley RJ; Department of Oncology, Torbay Hospital NHS Foundation Trust., Lee AJ; UCL Cancer Institute, University College London; University College London Hospitals NHS Trust., Lomas O; Department of Oncology, Oxford University Hospitals NHS Foundation Trust., Liu JK; Leeds Institute of Medical Research at St James's, University of Leeds., McCauley A; UK Health Security Agency (UKHSA)., Pang M; UK Department of Health and Social Care (DHSC)., Pascoe JS; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust., Platt JR; Leeds Institute of Medical Research at St James's, University of Leeds., Patel G; Cancer Division, UCL Cancer Institute, University College London., Patel V; NHS England., Potter VA; Department of Oncology, University Hospital Coventry and Warwickshire., Randle A; Royal College of Physicians., Rigg AS; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust., Robinson TM; Population Health Sciences, University of Bristol., Roques TW; Cancer Services, Norfolk and Norwich University Hospitals NHS Foundation Trust., Roux RL; Department of Oncology, Oxford University Hospitals NHS Foundation Trust., Rozmanowski S; Cancer Division, UCL Cancer Institute, University College London., Taylor H; Oxford Medical School, University of Oxford., Tuthill MH; Department of Oncology, Oxford University Hospitals NHS Foundation Trust., Watts I; Department of Academic Oncology, Royal Free Hospital., Williams S; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust., Beggs A; Institute of Cancer and Genomic Sciences, University of Birmingham., Iveson T; Cancer Sciences, University of Southampton., Lee SM; UCL Cancer Institute, University College London; University College London Hospitals NHS Trust; CRUK Lung Cancer Centre of Excellence, University College London., Middleton G; Institute of Immunology and Immunotherapy, University of Birmingham; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust., Middleton M; Department of Oncology, University of Oxford., Protheroe A; Department of Oncology, Oxford University Hospitals NHS Foundation Trust., Fittall MW; Cancer Division, UCL Cancer Institute, University College London., Fowler T; UK Health Security Agency (UKHSA)., Johnson P; Department of Oncology, University Hospital Coventry and Warwickshire; Cancer Sciences, University of Southampton.

مؤلفون مشاركون: UK Coronavirus Cancer Programme

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Nov; Vol. 175, pp. 1-10. Date of Electronic Publication: 2022 Jul 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/epidemiology , COVID-19*/prevention & control , Neoplasms*, Hospitalization ; Humans ; Pandemics ; Vaccination ; Vaccine Efficacy

المؤلفون: Lee LYW; Department of Oncology, University of Oxford, Oxford, UK; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. Electronic address: lennard.lee@oncology.ox.ac.uk., Starkey T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Ionescu MC; UK Health Security Agency, London, UK., Little M; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Tilby M; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Tripathy AR; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Mckenzie HS; Oncology Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Al-Hajji Y; Birmingham Medical School, University of Birmingham, Birmingham, UK., Barnard M; UK Health Security Agency, London, UK., Benny L; UK Health Security Agency, London, UK., Burnett A; NHS England, London, UK; NHS Improvement, London, UK., Cattell EL; Department of Cancer, Taunton and Somerset NHS Foundation Trust, Taunton, UK., Charman J; National Disease Registration Service, NHS Digital, London, UK., Clark JJ; Department of Surgery and Cancer, Imperial College London, London, UK., Khan S; Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Ghafoor Q; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Illsley G; UK Health Security Agency, London, UK., Harper-Wynne C; Kent Oncology Centre, University of Kent and Kent and Medway Medical School, Maidstone, UK., Hattersley RJ; Department of Oncology, Torbay Hospital NHS Foundation Trust, Torquay, UK., Lee AJX; UCL Cancer Institute, University College London Hospitals NHS Trust and University College London, London, UK., Leonard PC; Cancer Services, Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK., Liu JKH; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Pang M; Department of Health and Social Care, London, UK., Pascoe JS; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Platt JR; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Potter VA; Department of Oncology, University Hospital Coventry and Warwickshire, Coventry, UK., Randle A; Royal College of Physicians, London, UK., Rigg AS; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Robinson TM; Population Health Sciences, University of Bristol, Bristol, UK., Roques TW; Cancer Services, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Roux RL; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Rozmanowski S; Department of Health and Social Care, London, UK., Tuthill MH; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Watts I; Department of Academic Oncology, Royal Free Hospital, London, UK., Williams S; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Iveson T; Cancer Sciences, University of Southampton, Southampton, UK., Lee SM; UCL Cancer Institute, University College London Hospitals NHS Trust and University College London, London, UK; CRUK Lung Cancer Centre of Excellence, University College London Hospitals NHS Trust and University College London, London, UK., Middleton G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Middleton M; Department of Oncology, University of Oxford, Oxford, UK., Protheroe A; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Fittall MW; Cancer Services, The Royal Marsden NHS Foundation Trust, London, UK., Fowler T; UK Health Security Agency, London, UK., Johnson P; NHS England, London, UK; Cancer Sciences, University of Southampton, Southampton, UK.

مؤلفون مشاركون: NCRI Consumer Forum

المصدر: The Lancet. Oncology [Lancet Oncol] 2022 Jun; Vol. 23 (6), pp. 748-757. Date of Electronic Publication: 2022 May 23.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/epidemiology , COVID-19*/prevention & control , Neoplasms*/epidemiology , Viral Vaccines*, Adolescent ; Adult ; COVID-19 Vaccines ; Case-Control Studies ; Humans ; SARS-CoV-2 ; Vaccine Efficacy

SCR Disease Name: COVID-19 breakthrough infections

المؤلفون: McKenzie HS; University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Southampton, SO16 6YD, UK. Hayley.mckenzie@uhs.nhs.uk., Maishman T; Southampton Clinical Trials Unit, Southampton General Hospital, Southampton, SO16 6YD, UK., Simmonds P; University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Southampton, SO16 6YD, UK., Durcan L; Southampton Clinical Trials Unit, Southampton General Hospital, Southampton, SO16 6YD, UK., Eccles D; University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Southampton, SO16 6YD, UK., Copson E; University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Southampton, SO16 6YD, UK.

مؤلفون مشاركون: POSH Steering Group

المصدر: British journal of cancer [Br J Cancer] 2020 May; Vol. 122 (11), pp. 1618-1629. Date of Electronic Publication: 2020 Mar 31.

نوع المنشور: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*pathology , Neoplasm Recurrence, Local/*pathology, Adolescent ; Adult ; BRCA2 Protein/genetics ; Breast Neoplasms/genetics ; Breast Neoplasms/mortality ; Cohort Studies ; Female ; Humans ; Mutation ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/mortality ; Prognosis ; Progression-Free Survival ; Prospective Studies ; United Kingdom ; Young Adult

المؤلفون: McKenzie HS; University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Southampton, United Kingdom. Electronic address: h.s.mckenzie@soton.ac.uk., Mead G; University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Southampton, United Kingdom., Huddart R; The Royal Marsden NHS Foundation Trust, The Royal Marsden Hospital, Sutton, United Kingdom., White JD; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Rustin GJS; Mount Vernon Cancer Centre, Mount Vernon Hospital, Northwood, United Kingdom., Hennig IM; Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, United Kingdom., Cozens K; Southampton Clinical Trials Unit, University of Southampton, Southampton General Hospital, Southampton, United Kingdom., Cross N; Southampton Clinical Trials Unit, University of Southampton, Southampton General Hospital, Southampton, United Kingdom., Bowers M; Southampton Clinical Trials Unit, University of Southampton, Southampton General Hospital, Southampton, United Kingdom., Wheater MJ; University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Southampton, United Kingdom.

المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2018 Dec; Vol. 16 (6), pp. 458-465.e2. Date of Electronic Publication: 2018 Jul 17.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Deoxycytidine/*analogs & derivatives , Neoplasm Recurrence, Local/*drug therapy , Neoplasms, Germ Cell and Embryonal/*drug therapy , Salvage Therapy/*methods, Adult ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Drug Resistance, Neoplasm ; Female ; Humans ; Ifosfamide/administration & dosage ; Ifosfamide/adverse effects ; Male ; Maximum Tolerated Dose ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasms, Germ Cell and Embryonal/mortality ; Neoplasms, Germ Cell and Embryonal/pathology ; Salvage Therapy/adverse effects ; Survival Rate ; Taxoids/administration & dosage ; Taxoids/adverse effects ; Treatment Failure ; Young Adult ; Gemcitabine

SCR Protocol: TIP regimen

المؤلفون: Illidge TM; Manchester Academic Health Sciences Centre, University of Manchester, Christie NHS Foundation Trust, Manchester, UK., McKenzie HS; NIHR/Cancer Research UK Experimental Cancer Medicine Centre, Southampton, UK., Mayes S; Manchester Academic Health Sciences Centre, University of Manchester, Christie NHS Foundation Trust, Manchester, UK., Bates A; NIHR/Cancer Research UK Experimental Cancer Medicine Centre, Southampton, UK., Davies AJ; NIHR/Cancer Research UK Experimental Cancer Medicine Centre, Southampton, UK., Pettengell R; Department of Haematology, St Georges University of London, London, UK., Stanton L; Southampton Clinical Trials Unit, Southampton, UK., Cozens K; Southampton Clinical Trials Unit, Southampton, UK., Hampson G; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Dive C; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Zivanovic M; Manchester Academic Health Sciences Centre, University of Manchester, Christie NHS Foundation Trust, Manchester, UK., Tipping J; Manchester Academic Health Sciences Centre, University of Manchester, Christie NHS Foundation Trust, Manchester, UK., Gallop-Evans E; Clinical Trials Unit, Velindre Cancer Centre, Cardiff, UK., Radford JA; Manchester Academic Health Sciences Centre, University of Manchester, Christie NHS Foundation Trust, Manchester, UK., Johnson PW; NIHR/Cancer Research UK Experimental Cancer Medicine Centre, Southampton, UK.

المصدر: British journal of haematology [Br J Haematol] 2016 Apr; Vol. 173 (2), pp. 274-82. Date of Electronic Publication: 2016 Feb 05.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Immunotherapy/*methods , Lymphoma, Follicular/*therapy , Neoplasm Recurrence, Local/*therapy, Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Murine-Derived/administration & dosage ; Antibodies, Monoclonal, Murine-Derived/adverse effects ; Antineoplastic Agents/pharmacokinetics ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/adverse effects ; Doxorubicin/administration & dosage ; Doxorubicin/adverse effects ; Female ; Humans ; Immunotherapy/adverse effects ; Male ; Middle Aged ; Prednisone/administration & dosage ; Prednisone/adverse effects ; Prospective Studies ; Radioimmunotherapy/adverse effects ; Radioimmunotherapy/methods ; Radiopharmaceuticals/administration & dosage ; Radiopharmaceuticals/adverse effects ; Rituximab/pharmacokinetics ; Treatment Outcome ; Vincristine/administration & dosage ; Vincristine/adverse effects

المؤلفون: Knight MF, McKenzie HS

المصدر: Journal of applied behavior analysis [J Appl Behav Anal] 1974 Spring; Vol. 7 (1), pp. 33-8.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0174763 Publication Model: Print Cited Medium: Print ISSN: 0021-8855 (Print) Linking ISSN: 00218855 NLM ISO Abbreviation: J Appl Behav Anal Subsets: MEDLINE

مواضيع طبية MeSH: Reading* , Reinforcement, Psychology*, Fingersucking/*therapy, Child ; Child, Preschool ; Female ; Humans ; Male

المؤلفون: McKenzie HS, Clark M, Wolf MM, Kothera R, Benson C

المصدر: Exceptional children [Except Child] 1968 Summer; Vol. 34 (10), pp. 745-52.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Council For Exceptional Children Country of Publication: United States NLM ID: 0375042 Publication Model: Print Cited Medium: Print ISSN: 0014-4029 (Print) Linking ISSN: 00144029 NLM ISO Abbreviation: Except Child Subsets: MEDLINE

مواضيع طبية MeSH: Behavior Therapy* , Reinforcement, Psychology*, Learning Disabilities/*therapy, Achievement ; Adolescent ; Child ; Child Behavior ; Humans ; Methods